INDP Indaptus Therapeutics Inc
Company Analysis
Latest News
🔴 Indaptus Therapeutics is trading 5% down; no clear catalyst identified
Indaptus Therapeutics is trading 5.26% down at $2.70, with no clear catalyst identified for the October 16 move. - No fresh company announcement surfaced; the...
🟢 Indaptus Therapeutics is trading 14.7% up with no clear catalyst
Indaptus Therapeutics is trading 14.71% higher at $2.54, with the reason for the October 15 move unclear. - No fresh company announcement explaining the move...
🟢 Indaptus Therapeutics is trading 6.3% up
Indaptus Therapeutics is trading at $2.40, up +6.33%, with no verified catalyst identified for the rise. - No fresh company announcement explaining the October...
🔴 Indaptus Therapeutics is trading 10% down on October 14, 2026 amid hotter CPI and biotech weakness
Indaptus Therapeutics is trading at $2.15 (-10.04%) amid broader market pressure following hotter-than-expected headline CPI and weakness in biotech stocks. -...
🔴 Indaptus Therapeutics is trading 6.7% down
Indaptus Therapeutics is trading 6.7% down at $2.23, and the reason for the decline remains unclear. - No company announcement dated October 14 was identified;...
🟢 Indaptus Therapeutics is trading 7.3% up in pre-market
Indaptus Therapeutics is trading at $2.56, up 7.29% in pre-market; available evidence does not establish a specific cause. - The previous session closed at...
🟢 Indaptus Therapeutics is trading 5% up
Indaptus Therapeutics is trading 5.18% higher at $2.64 on October 12, 2026; no fresh company-specific announcement has been identified to explain the move. -...
🟢 Indaptus Therapeutics is trading 6.1% up
Indaptus Therapeutics is trading 6.1% higher at $2.52 on October 9, 2026, with no fresh company-specific announcement identified to explain the move. -...
🟢 Indaptus Therapeutics is trading 5.3% up
Indaptus Therapeutics is trading 5.31% higher at $2.38, with no clear catalyst identified for the October 8 move. - The available news check found no fresh...
🟢 Indaptus Therapeutics is trading 9.3% up in pre-market
Indaptus Therapeutics is trading at $2.47, up 9.29% in pre-market, with no fresh company-specific announcement identified to explain the rise. - Available...
🟢 Indaptus Therapeutics is trading 10.62% up in after-hours trading
Indaptus Therapeutics is trading 10.62% higher at $2.50 in after-hours trading, with no fresh company-specific announcement identified to explain the gain. -...
🔴 Indaptus Therapeutics is trading 10.42% down as global risk-off sentiment pressures shares
Indaptus Therapeutics is trading at $2.32, down 10.42%, as broad risk-off sentiment weighs on markets. - Major U.S. indices are lower amid rising yields, oil...
🔴 Indaptus Therapeutics is trading 8.24% down today amid broader equity and biotech pressure
Indaptus Therapeutics is trading 8.24% down at $2.38, with the decline consistent with broader equity and biotech weakness; no fresh company-specific catalyst...
🟢 Indaptus Therapeutics is trading 5.46% up
Indaptus Therapeutics is trading at $2.51, up 5.46%, with no verified catalyst identified for the move. - No verified company announcement or confirmed...
🔴 Indaptus Therapeutics is trading 5% down
Indaptus Therapeutics is trading 5.04% lower at $2.26, with no verified October 5 announcement or confirmed catalyst explaining the decline. - The latest...
🟢 Indaptus Therapeutics is trading 9.24% up in pre-market
Indaptus Therapeutics is trading at $2.60, up 9.24% in pre-market, with no clear catalyst identified. - No verified October 5 company announcement was found;...
🟢 Indaptus Therapeutics is trading 11% up today amid broader market rally; no company-specific catalyst identified
Indaptus Therapeutics is trading 10.61% up at $2.35 amid a broad market rally, though no direct cause for its move has been confirmed. - No verified...
🟢 Indaptus Therapeutics is trading 5.66% up today with no company-specific catalyst identified
Indaptus Therapeutics is trading at $2.24, up +5.66%, with no verified company-specific announcement explaining the October 2 move; broader market gains may be...
🔴 Indaptus Therapeutics is trading 8.25% down with no clear catalyst identified
Indaptus Therapeutics is trading 8.25% down at $1.95 on October 2, 2026, with no verified company-specific announcement explaining the move. - Shares closed...
🔴 Indaptus Therapeutics is trading 7.2% down
Indaptus Therapeutics is trading 7.17% lower at $2.13, with no specific company announcement identified to explain the October 1 move. - The pullback extends...